The first licensed vaccine to protect against canine influenza, recommended for puppies and dogs that interact in public settings.
NOBIVAC® CANINE FLU H3N8 PROVIDES INFLUENZA PROTECTION FOR DOGS
Canine Influenza (H3N8) Virus (inactivated virus). Demonstrated to reduce incidence and severity of lung lesions, as well as duration of coughing and viral shedding.
Proven to significantly reduce the clinical signs, severity, and spread of canine influenza infection1,12
Reduced the incidence and severity of coughing1
Decreased the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea1
Reduced the days and amount of viral shedding1
Demonstrated protection against the formation and severity of lung lesions1
Contains killed (type A, subtype H3N8) virus combined with an adjuvant to enhance the immune response
INDICATIONS:
This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine influenza virus.
NOBIVAC® CANINE FLU H3N8 IS A SAFE CHOICE
Safety confirmed through clinical use in more than 7 million dogs1
Well tolerated on subcutaneous administration
Proven safe across a multitude of dog breeds and ages
ADMINISTRATION AND DOSAGE
Subcutaneous injection
Two 1 mL doses given two to four weeks apart
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
NOBIVAC® CANINE FLU H3N8 LESSENS THE OPPORTUNITY FOR CIV TO INFECT OTHER DOGS12
Shown to reduce the duration and degree of nasal virus shedding.12
On Day 4, controls shed 500 times more viral particles than vaccinates
Mean viral shedding lasted only 2 days in vaccinates versus 5 days in controls
Vaccinates also shed less virus overall than controls
REDUCED CLINICAL SIGNS
NOBIVAC® CANINE FLU H3N8 IS HIGHLY EFFECTIVE IN REDUCING CLINICAL SIGNS OF CANINE INFLUENZA VIRUS (CIV) INFECTION12
Shown to significantly reduce the incidence of cough12
Reduced severity of cough12
LUNG PROTECTION
NOBIVAC® CANINE FLU H3N8 PROTECTS THE LUNGS12
In a canine influenza virus (CIV) challenge study, vaccinated dogs exhibited significantly fewer signs of consolidation and lung damage than dogs in the control group12
Nobivac® Canine Flu H3N8 was shown to provide protection by reducing disease severity, lung lesions, and shedding13
No items to show.
Loading…
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Nobivac® Social Media Kits
Digital Assets
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
